Newsletter

ITNS Is On High Alert Right Now!

These Sub-Penny Levels May Not Last!!

Dear PennyStockTitans Member,

Our last alert saw a nice jump of 40% quickly! 

Tonight's alert could be headed for an even bigger jump in the short term so hurry and start your research.

This is a SUB-PENNY stock that could be about to rally HUGE!

The ticker is: ITNS

ITNS looks like it could be setting up for a major breakout. The stock in the last 2 weeks has soared almost 100%!

Moving from as low as $0.0045 on 12/16 to as high as $0.0088 this past Friday!

Wall Street is starting to pay attention to the company and the big things it has going on.

2015 could be a breakthrough year for the company as ITNS has a nausea relief product that could become a household name in medicine. 

Not only that but ITNS has an app that's scheduled for release next year that could be a game changer in the legal marijuana industry!

This is an alert to NOT ignore!

You could be looking at GROUND-FLOOR levels right now and they may not last much longer!

Current Share Price: $0.0084

ITNS is no stranger to rallies. The stock has seen breakouts with gains over 100% several times!

With the recent move up, ITNS could be gearing up for some bigger moves.

About the Company:

ITNS is focused on becoming a market leader in the distribution of innovative products to the medical and pharmaceutical industry. 

One of the most common things we can experience is nausea and this company has a product that could offer quick relief from it!

The company is working on marketing an anti-nausea product called Emesyl that could very fast become a HOUSEHOLD NAME!

ITNS will market Emesyl to national retailers, including: 

Drugstore retailers

Department stores

Cruiselines, and 

Other strategic retail sectors

Some common causes of nausea are motion sickness, dizziness, migraine, fainting, gastroenteritis (stomach infection) or food poisoning. Side effects of many medications including cancer chemotherapy, nauseants or morning sickness in early pregnancy. Nausea may also be caused by anxiety, disgust, or depression.

The market for a homeopathic product that can combat nausea could be monstrous for ITNS!

Something very significant to note is that Emesyl was invented by Dr. Charles H. Hensley who also invented Zicam Cold Remedy!

Zicam became a household name and forever changed the paradigm for homeopathic drugs in the U.S. Could he do the same for Emesyl soon!?

Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.

You can check out the Emesyl website here: www.emesyl.com

ITNS recently received confirmation from its manufacturer, Oasis Health Products, that its Emesyl(R) nausea relief product has passed its Stability Test to enable the company to market Emesyl(R) with a 2-year expiration date.

"We are pleased to see the successful completion of the 90-day stability test which will enable the Company to package and sell Emesyl(R) with a 2-year expiration," said Mark Cheung, CEO of Itonis, Inc. "We appreciate our shareholders' support and patience, and are eager to begin the selling of Emesyl(R) to generate revenues for the Company."

The Company also looks forward to delivery of the MyECheck, Inc. point-of-sale app in early 2015.

HUGE OPPORTUNITIES IN THE LEGAL MJ SECTOR!

One of the hottest sectors right now is marijuana. America's marijuana industry is worth billions. Much like the dot.com boom of the 90s, many are looking at medical marijuana as the next ticket to riches! 

Back in March, ITNS signed a Licensing Agreement with MyECheck, Inc. for the company to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.

Due to existing banking limitations, marijuana dispensaries are conducting all their financial transactions strictly on a "cash only" basis, even in states where the sale of marijuana is legal. 

The MyECheck mobile app will allow consumers and dispensaries the security and convenience of a non-cash alternative to complete their transactions!

This could be a HUGE revenue opportunity for ITNS!

ITNS is trading at UNDER ONE PENNY so imagine the potential for big gains at such low levels when the company has two products that could become huge next year!!

We could soon be seeing ITNS run very big if Wall Street discovers it!

Could gains of 100%+ be on the way??

Sincerely,

PennyStockTitans

GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY

We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Pennystocktitans.com sponsored advertisements do not purport to provide an analysis of any company's financial position, operations or prospects and this is not to be construed as a recommendation by Pennystocktitans.com or an offer or solicitation to buy or sell any securities.

None of the owners of Pennystocktitans.com, or any of its members, officers, directors, contractors or employees is a licensed broker-dealer, account representative, market maker, investment banker, investment advisor, analyst or underwriter. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Pennystocktitans.com makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.

Pennystocktitans.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Pennystocktitans.com  has no obligation to update any of the information provided, nor is it responsible for errors and omissions.

From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our releases or on our website may not have approved certain or any statements within the release or website. Pennystocktitans.com  encourages viewers to supplement the information obtained from any release or our website with independent research and other professional advice. By accessing, viewing, or using our website or communications originating from our website or any release therein, you agree that Pennystocktitans.com, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Pennystocktitans.com, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

Pennystocktitans.com uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. You agree to hold Pennystocktitans.com, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. Pennystocktitans.com  disclaims all warranties of any kind, express or implied. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or then FINRA at: www.finra.org . In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/investors/index.htm.

Questions regarding any information contained in this website may be sent to info@pennystocktitans.com To review our complete disclaimer and additional information, please visit www.pennystocktitans.com

COMPANY SPECIFIC DISCLAIMER

Some of the content in this release may contain forward-looking information within the meaning of Section 27 A of the Securities Act of 1933 and Section 21 E of the Securities Exchange Act of 1934 including statements regarding expected continual growth of the profiled companies and the value of their securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect the company's actual results of operation. The company's actual performance could greatly differ from those described in any forward looking statements or announcements mentioned in our releases. A company's past performance does not guarantee future results. Further specific financial information, filings and disclosures as well as general investor information about the profiled companies, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org.

The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. This release may provide hyperlinks to third party websites or access to third party content. Pennystocktitans.com, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Pennystocktitans.com control, endorse, or guarantee any content found in such sites.

Pennystocktitans.com expectes to be compensated $25,000.00  in cash compensation from QTAR LLC  for the 1 day profile of Itonis  (OTCBB:ITNS) which services include the issuance of this release and other opinions that we release concerning of  Itonis  (OTCBB:ITNS).Pennystocktitans.com  has not investigated the background of QTAR LLC , the hiring party, or Itonis  (OTCBB:ITNS). Anyone viewing this newsletter should assume QTAR LLC or affiliates of QTAR LLC own shares of Itonis  (OTCBB:ITNS) of which they plan to liquidate, and further understand that the liquidation of those shares may or may not negatively impact the share price. Pennystocktitans.com has received this amount as a production budget for advertising efforts and will retain amounts over and above the cost of production, copywriting services, mailing and other distribution expenses as a fee for our services. As such, our opinion is neither unbiased nor independent, and you should consider that when evaluating our statements Itonis  (OTCBB:ITNS).